Skip to content
home HOME 研发 使命 & 愿景 研发管线

研发管线

YRI顺应市场需求,聚焦需求最集中的主要领域,提高研发成功率,确保创新药物的研发管线。目前,YRI的重点研发领域为心血管及代谢疾病、炎症及免疫力障碍以及抗癌药。YRI加强与国际学术研究中心、合作投资机构、政府研究机构的合作,持续强化有竞争力的医药研发管线。强化研发管线可促进技术合作输出许可的签约,巩固并提升柳韩洋行在国际市场的竞争力。

Gastrointestinal Disorder

Gastrointestinal Disorder
产品 适应症 Discovery Preclinical Phase 1 Phase 2 Phase 3
YH12852 术后肠梗阻
Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2

Cardiovascular Disorder

Cardiovascular Disorder
产品 适应症 Discovery Preclinical Phase 1 Phase 2 Phase 3
YH22162 高血压
YH-NCE6 非酒精性脂肪性肝炎
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-NCE5 非酒精性脂肪性肝炎
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH25724 非酒精性脂肪性肝炎
PreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinical
YH-BIO4 肥胖症
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-NCE9 非酒精性脂肪性肝炎
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-NCE10 戈谢病,法布瑞氏症,帕金森症
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery

Immunology/Inflammation

Immunology/Inflammation
产品 适应症 Discovery Preclinical Phase 1 Phase 2 Phase 3
YH-siRNA1 瘢痕疙瘩
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-NCE1 哮喘
PreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinical
YH14618 退变性椎间盘疾病
Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2
YH1713 类风湿性关节炎
Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1

Oncology

Oncology
产品 适应症 Discovery Preclinical Phase 1 Phase 2 Phase 3
YH-siRNA2 肝癌
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-BIO3 免疫肿瘤
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-BIO2 免疫肿瘤
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
TH29143 免疫肿瘤
PreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinical
YH-NCE7 免疫肿瘤
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-NCE4 RCC
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-NCE3 肺癌
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-NCE2 肝癌
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH24931 免疫肿瘤
Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1Phase 1
Lazertinib (YH25448) 肺癌
Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3Phase 3
YH25247 免疫肿瘤
PreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinicalPreclinical
YH-BIO5 免疫肿瘤
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-BIO6 免疫肿瘤
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-BIO7 免疫肿瘤
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-BIO8 免疫肿瘤
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery
YH-BIO9 免疫肿瘤
DiscoveryDiscoveryDiscoveryDiscoveryDiscovery